An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
The demand for biologic drugs continues to grow at a steady 12–14% annually. To keep up, biotech and biopharma developers are increasingly relying on outsourcing partners to meet both clinical and commercial research, development, and production needs.
Source: biopharma-reporter.com